144 related articles for article (PubMed ID: 36650724)
1. Investigating the role of delayed contrast magnetic resonance imaging (MRI) to differentiate radiation necrosis from tumour recurrence in brain metastases after stereotactic radiosurgery.
Admojo L; Korte J; Anderson N; Phillips C; Caspersz L; Lasocki A
J Med Imaging Radiat Oncol; 2023 Apr; 67(3):292-298. PubMed ID: 36650724
[TBL] [Abstract][Full Text] [Related]
2. The Use of Treatment Response Assessment Maps in Discriminating Between Radiation Effect and Persistent Tumoral Lesion in Metastatic Brain Tumors Treated with Gamma Knife Radiosurgery.
Peker S; Samanci Y; Aygun MS; Yavuz F; Erden ME; Nokay AE; Atasoy Aİ; Bolukbasi Y
World Neurosurg; 2021 Feb; 146():e1134-e1146. PubMed ID: 33253956
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of Lesions after Stereotactic Radiosurgery for Brain Metastases: Impact of Delayed Contrast Magnetic Resonance Imaging.
Wagner S; Gufler H; Eichner G; Lanfermann H
Clin Oncol (R Coll Radiol); 2017 Mar; 29(3):143-150. PubMed ID: 27777145
[TBL] [Abstract][Full Text] [Related]
4. Leveraging radiomics and machine learning to differentiate radiation necrosis from recurrence in patients with brain metastases.
Basree MM; Li C; Um H; Bui AH; Liu M; Ahmed A; Tiwari P; McMillan AB; Baschnagel AM
J Neurooncol; 2024 Jun; 168(2):307-316. PubMed ID: 38689115
[TBL] [Abstract][Full Text] [Related]
5. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
[TBL] [Abstract][Full Text] [Related]
6. What effective technique to differentiate radiation brain necrosis from a tumor progression in patients treated with radiation: A monocentric retrospective study combining the MRI TRAMs technique and the (
Lakehayli Z; Phlips P; Margoum A; Saoudi A; Hmaid L; Nejjar I; Oueslati H; Bourgois N; Dao S; Belkhir F
Cancer Radiother; 2023 Jun; 27(4):273-280. PubMed ID: 37080856
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing Brain Metastasis Progression From Radiation Effects After Stereotactic Radiosurgery Using Longitudinal GRASP Dynamic Contrast-Enhanced MRI.
Berger A; Lee MD; Lotan E; Block KT; Fatterpekar G; Kondziolka D
Neurosurgery; 2023 Mar; 92(3):497-506. PubMed ID: 36700674
[TBL] [Abstract][Full Text] [Related]
8. Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases.
Leeman JE; Clump DA; Flickinger JC; Mintz AH; Burton SA; Heron DE
Neuro Oncol; 2013 Dec; 15(12):1732-8. PubMed ID: 24243914
[TBL] [Abstract][Full Text] [Related]
9. MRI Treatment Response Assessment Maps (TRAMs) for differentiating recurrent glioblastoma from radiation necrosis.
Müller SJ; Khadhraoui E; Ganslandt O; Henkes H; Gihr GA
J Neurooncol; 2024 Feb; 166(3):513-521. PubMed ID: 38261142
[TBL] [Abstract][Full Text] [Related]
10. [PET scan and NMR spectroscopy for the differential diagnosis between brain radiation necrosis and tumour recurrence after stereotactic irradiation of brain metastases: Place in the decision tree].
Menoux I; Noël G; Namer I; Antoni D
Cancer Radiother; 2017 Aug; 21(5):389-397. PubMed ID: 28599998
[TBL] [Abstract][Full Text] [Related]
11. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
Donovan EK; Parpia S; Greenspoon JN
Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
[TBL] [Abstract][Full Text] [Related]
12. Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery.
Stockham AL; Tievsky AL; Koyfman SA; Reddy CA; Suh JH; Vogelbaum MA; Barnett GH; Chao ST
J Neurooncol; 2012 Aug; 109(1):149-58. PubMed ID: 22638727
[TBL] [Abstract][Full Text] [Related]
13. Imaging changes over 18 months following stereotactic radiosurgery for brain metastases: both late radiation necrosis and tumor progression can occur.
Fujimoto D; von Eyben R; Gibbs IC; Chang SD; Li G; Harsh GR; Hancock S; Fischbein N; Soltys SG
J Neurooncol; 2018 Jan; 136(1):207-212. PubMed ID: 29098569
[TBL] [Abstract][Full Text] [Related]
14. Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis.
Narloch JL; Farber SH; Sammons S; McSherry F; Herndon JE; Hoang JK; Yin FF; Sampson JH; Fecci PE; Blackwell KL; Kirkpatrick JP; Kim GJ
Neuro Oncol; 2017 Oct; 19(10):1391-1397. PubMed ID: 28472527
[TBL] [Abstract][Full Text] [Related]
15. Delayed contrast extravasation MRI: a new paradigm in neuro-oncology.
Zach L; Guez D; Last D; Daniels D; Grober Y; Nissim O; Hoffmann C; Nass D; Talianski A; Spiegelmann R; Tsarfaty G; Salomon S; Hadani M; Kanner A; Blumenthal DT; Bukstein F; Yalon M; Zauberman J; Roth J; Shoshan Y; Fridman E; Wygoda M; Limon D; Tzuk T; Cohen ZR; Mardor Y
Neuro Oncol; 2015 Mar; 17(3):457-65. PubMed ID: 25452395
[TBL] [Abstract][Full Text] [Related]
16. A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images.
Zhang Z; Yang J; Ho A; Jiang W; Logan J; Wang X; Brown PD; McGovern SL; Guha-Thakurta N; Ferguson SD; Fave X; Zhang L; Mackin D; Court LE; Li J
Eur Radiol; 2018 Jun; 28(6):2255-2263. PubMed ID: 29178031
[TBL] [Abstract][Full Text] [Related]
17. SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases.
Crouzen JA; Petoukhova AL; Broekman MLD; Fiocco M; Fisscher UJ; Franssen JH; Gadellaa-van Hooijdonk CGM; Kerkhof M; Kiderlen M; Mast ME; van Rij CM; Nandoe Tewarie R; van de Sande MAE; van der Toorn PPG; Vlasman R; Vos MJ; van der Voort van Zyp NCMG; Wiggenraad RGJ; Wiltink LM; Zindler JD
BMC Cancer; 2023 Mar; 23(1):273. PubMed ID: 36964529
[TBL] [Abstract][Full Text] [Related]
18. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
[TBL] [Abstract][Full Text] [Related]
19. Identification and Management of Progressive Enhancement After Radiation Therapy for Brain Metastases: Results from a Neurosurgical Survey.
Semonche A; Patel NV; Yang I; Danish SF
World Neurosurg; 2020 Jul; 139():e526-e540. PubMed ID: 32311550
[TBL] [Abstract][Full Text] [Related]
20. Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery.
Mitsuya K; Nakasu Y; Horiguchi S; Harada H; Nishimura T; Bando E; Okawa H; Furukawa Y; Hirai T; Endo M
J Neurooncol; 2010 Aug; 99(1):81-8. PubMed ID: 20058049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]